Brief: Genetic Analysis As 9 Month Operating Income Amounted To Nok 16,8 Million (Nok 15,1 Million)
02/11/2023 19:13
Nov 2 (Reuters) - Genetic Analysis AS GEAN.TE :
* 9 MONTH OPERATING INCOME AMOUNTED TO NOK 16,8 MILLION (NOK
15,1
MILLION)
* Q1 TO Q3 EARNINGS PER SHARE AMOUNTED TO NOK -0,69 (-0,82)
* 9 MONTH SALES AMOUNTED TO NOK 10,3 MILLION (NOK 7,7
MILLION)
Source text for Eikon: ID:nWkr5CyRtr
Further company coverage: GEAN.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Analysis As
See all newsNorway's Genetic Analysis Q1 gross margin hurt by US duties, currency impact
Brief: Genetic Analysis As 9 Month Operating Income Amounted To Nok 16,8 Million (Nok 15,1 Million)
Brief: Genetic Analysis Q3 Net Income NOK -4.3 Million
Brief: Genetic Analysis Q2 Sales at NOK 3.7 Million
Brief: Genetic Analysis Ramps Up Market Presence For Ga-Map Microbiome Testing In U.S.